Proteomic Exploration of L1CAM+-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson’s Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311564 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mary Xylaki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Medical Center Göttingen, 37075 Göttingen, Germany. Hauptthemen laut MEDLINE: Parkinson Disease, Extracellular Vesicles, Neural Cell Adhesion Molecule L1, Proteomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche, Biogen, Bial.
Abstract (Originalsprache)
L1 cell adhesion molecule (L1CAM)-positive extracellular vesicles (EVs) are being explored as a potential source of biomarkers for Parkinson’s disease (PD) in peripheral blood. However, their utility remains controversial. In this study, we sought to investigate the proteome composition of L1CAM+-EVs isolated from human blood plasma and evaluate their potential as biomarkers for PD. L1CAM+-EVs were extracted from blood plasma using direct immunoprecipitation by employing magnetic beads coupled to an anti-L1CAM antibody. The Proximity Extension Assay platform, Olink Explore 3072, was used to analyze samples from 60 individuals: 20 healthy controls (HC), 20 patients with isolated REM sleep behavior disorder (iRBD), and 20 PD patients. Targeted proteomic analysis identified 2841 proteins in L1CAM+-EVs, of which 203 exhibited differential expression across groups. Although these changes were not statistically significant, after correction for multiple testing, a combination of 12 proteins could discriminate between PD and HC. Moreover, several proteins displayed trends toward upregulation or downregulation in PD and iRBD when compared with HC. These preliminary findings suggest that L1CAM+-EVs proteins show some potential as biomarkers for PD; however, further investigation and validation studies are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University Medical Center Göttingen, 37075 Göttingen, Germany.
- Institute for Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, 37075 Göttingen, Germany.
- Paracelsus-Elena Klinik, 34128 Kassel, Germany.
- Department of Clinical Chemistry, University Medical Center Göttingen, 37075 Göttingen, Germany.
- Bioanalytical Mass Spectrometry, Max Planck Institute for Multidisciplinary Sciences, 37077 Göttingen, Germany.
ORCID-Profile: Mary Xylaki, Yevheniia Kyriachenko, Jannik Scherer, Mohammed Dakna, Michael Bartl, Sebastian Schade, Christof Lenz
Förderung
- Roche
- Biogen
- Bial
- AbbVie
- Servier
- 4D Pharma PLC
- Amprion
- the Deutsche Forschungsgemeinschaft
Zitieren
APA
Xylaki, M., Chopra, A., Kyriachenko, Y., Scherer, J., Otte, B., Dakna, M., Bartl, M., Weber, S., Schade, S., Lenz, C., & Mollenhauer, B. (2025). Proteomic Exploration of L1CAM+-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311564
Vancouver
Xylaki M, Chopra A, Kyriachenko Y, Scherer J, Otte B, Dakna M, et al. Proteomic Exploration of L1CAM+-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson’s Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311564
BibTeX
@article{Xylaki2025,
author = {Xylaki, Mary and Chopra, Avika and Kyriachenko, Yevheniia and Scherer, Jannik and Otte, Birgit and Dakna, Mohammed and Bartl, Michael and Weber, Sandrina and Schade, Sebastian and Lenz, Christof and Mollenhauer, Brit},
title = {Proteomic Exploration of L1CAM+-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311564}
}
EUVIMED